戻る
Delivra Health Brands Inc. (DHBUF)価格
DHBUF 株価推移チャート
DHBUF 収入
Delivra Health Brands Inc.
$0.14
-5.93%
$0
終値： Jan 23, 16:00:00 GMT-5
$0.14
0%
$0
アフターマーケット：Jan 23, 17:43:08 GMT-5
Earnings FAQ
DHBUFの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Delivra Health Brands Inc. DHBUFの前四半期の収益はどうでしたか？
Delivra Health Brands Inc.の収益見積もりはいくらですか？
Delivra Health Brands Inc.の収益品質スコアはどれくらいですか？
Delivra Health Brands Inc.はいつ収益を報告しますか？
Delivra Health Brands Inc.の予想収益はいくらですか？
Delivra Health Brands Inc.は収益予想を上回りましたか？
主要データ
前終値
$0.15
始値
$0.1492
当日レンジ
$0.1411 - $0.1492
52週レンジ
$0.0057 - $0.2612
取引高
405
平均取引高
5.8K
1株当たり利益(TTM)
-0.02
配当利回り
--
時価総額
$4.4M
DELIVRA HEALTH BRANDS INC.とは何ですか？
Delivra Health Brands, Inc. is a cannabis company, which engages in the development and provision of health and wellness packaged goods to consumers and patients in regulated markets. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-02. The firm provides products that help with pain, sleep, anxiety, and performance through its brands LivRelief and Dream Water. The company operates a portfolio of brands under its Consumer Division consisting of Dream Products Inc. and Delivra Corp. Dream Water provides non-habit-forming sleep solutions in formats to suit various consumer needs. The company features its proprietary SleepStat blend, a combination of melatonin, gamma-aminobutyric acid, and 5-hydroxytryptophan. Its product range includes 74ml (2.5oz) liquid sleep shots, gummies, and powder. Delivra Corp. manufactures and sells a growing line of topical creams with the proprietary transdermal delivery system platform under the LivRelief brand for conditions, such as joint and muscle pain, nerve pain, varicose veins, and wound healing creams. LivRelief Infused launched cannabidol and tetrahydrocannabinol-infused topical formulations through licensing agreements.